Breaking News

Vaccinia virus-specific molecular signature in atopic dermatitis skin

Vaccinia virus-specific molecular signature in atopic dermatitis skin

 
 

A study to identify the differences in the transcriptional response to vaccinia virus (VV) in patients with atopic dermatitis (AD; n = 12) pr psoriasis (n = 12) versus healthy controls (n = 13) was conducted. The aim was to identify a defective pathway or pathways that may be involved in eczema vaccinatum (EV). Sixty-seven genes were significantly affected by VV in AD but not psoriatic or healthy skin. Genes associated with defense, response to wounding and immunity were predominantly affected. Skin gene expression was highly correlated with the Eczema Area and Severity Index (EASI) for certain genes such as Toll-like receptor 4 (r = -0.742; P = 0.0138); orosomucoid ...

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list